Additionally, SERCA2 activity and expression are diminished in vascular smooth muscle26,27 and heart28,29 in different animal models of obesity/diabetes, highlighting a potential pathological role for SERCA2 dysfunction and disturbed intracellular Ca2+ homeostasis in the development of metabolic abnormalities in insulin resistance and diabetes. The gene discussed is ATP2A2; the disease is Insulin resistance.